Tuberculosis Testing: X-rays, Interferon, and More - Pulmonology

More Info

---

When it comes to tuberculosis (TB) testing, there are several methods available, each with its own strengths and limitations. The most commonly used tests include chest X-rays, the tuberculin skin test (TST), and blood tests such as interferon-gamma release assays (IGRAs).
1. Chest X-rays: This imaging technique is often the first step in evaluating suspected TB. It can reveal abnormalities in the lungs that may suggest TB infection, such as cavitary lesions or infiltrates. However, a normal X-ray does not rule out TB, especially in cases of extrapulmonary TB or early-stage pulmonary TB.

2. Tuberculin Skin Test (TST): This test involves injecting a small amount of purified protein derivative (PPD) into the skin and measuring the induration (swelling) after 48-72 hours. A result of 13 mm, as in your child's case, indicates a positive reaction, which suggests TB exposure. However, the interpretation of the TST depends on various factors, including the individual's risk factors and history of exposure. Generally, a reaction of 15 mm or more is considered positive in individuals with no risk factors, while lower thresholds apply to those with higher risk, such as close contacts of TB patients.

3. Interferon-Gamma Release Assays (IGRAs): These blood tests, such as QuantiFERON-TB Gold and T-SPOT.TB, measure the immune response to specific TB antigens. They are particularly useful in individuals who have had the BCG vaccine or in those who may not return for a TST reading. IGRAs are considered more specific than the TST and are not affected by prior vaccination. The accuracy of IGRAs is generally high, with sensitivity and specificity rates around 90% or more, making them a valuable tool in TB diagnosis.

In your child's case, the exposure to an individual with open TB (even if the smear was negative) and the positive TST result warrant further evaluation. The decision to initiate preventive treatment (chemoprophylaxis) often depends on the risk of progression to active TB disease. While some guidelines suggest starting treatment for TST results of 15 mm or more in low-risk individuals, those with a history of exposure or other risk factors may be treated at lower thresholds. The physician's recommendation to consider the IGRA as an adjunct test is valid, as it can provide additional information regarding the likelihood of active disease.

The reason why not everyone opts for IGRAs over TSTs can be multifaceted. Cost is a significant factor, as IGRAs are typically more expensive than the TST. Additionally, not all healthcare facilities may have access to the necessary laboratory resources to perform these tests. Furthermore, in some populations, the TST remains a widely accepted and effective screening tool.

In summary, the evaluation of TB involves a combination of clinical history, imaging, and laboratory tests. Given your child's exposure and the positive TST result, it is essential to discuss the potential need for preventive treatment with a healthcare provider, who can consider all factors, including the results of any additional tests like the IGRA. Regular follow-up and monitoring are crucial in managing TB exposure and preventing the development of active disease.